Cassava Sciences Inc (NASDAQ:SAVA)
| 29.64 Delayed Data As of Feb 06 |  -1.28 / -4.14%Today’s Change | 13.84 Today|||52-Week Range 62.49 | +0.34% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Robertson Sanford R Director |  Buy | 8/12/2022 | 100,000 | $20.69 | $2.1M | +44.91% |
Barbier Remi President & Chief Executive Officer |  Sale | 6/06/2022 | 54,720 | $27.93 | $1.5M | +5.94% |
Barbier Remi President & Chief Executive Officer | Buy | 6/06/2022 | 65,368 | $23.38 | $1.5M | +5.94% |
Barry Richard Jon Director | Buy | 8/23/2022 | 36,159 | $23.79 | $860.2K | +16.91% |
Friedmann Nadav Chief Medical Officer | Sale | 5/27/2022 | 21,498 | $26.66 | $573.1K | +10.99% |
Friedmann Nadav Chief Medical Officer | Buy | 5/27/2022 | 24,513 | $23.38 | $573.1K | +10.99% |
Gussin Robert Z Director | Sale | 3/29/2022 | 4,024 | $39.98 | $160.9K | -25.99% |
Robertson Sanford R Director | Buy | 3/25/2022 | 4,670 | $20.30 | $94.8K | -26.34% |
Gussin Robert Z Director | Buy | 3/29/2022 | 4,669 | $20.30 | $94.8K | -25.99% |
Friedmann Nadav Chief Medical Officer | Sale | 5/27/2022 | 3,071 | $26.66 | $81.9K | +10.99% |
Page of 2